sözaltı news Finance
Finance
EN AZ
Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?

Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?

finance.yahoo.com 29.08.2026 00:26 1 views